CNPR PHARMACEUTICAL EXAM Q AND A
◉ What should you do if you receive a shipment from your employer
and you notice that there are twice as many samples as what is
posted on the packing slip?
Answer: Call your Sales Manager and inform him/her of the mistake,
and ask for instructions on proper procedure.
◉ Which area of drug R&D has seen the largest cost increases?
Answer: Clinical trials.
◉ On average, how long does it take for a new drug to be developed
(i.e. from the discovery of the initial compound to FDA approval)?
Answer: 10-15 years
◉ Which of the following agencies is industry-based (i.e. run mainly
by the companies themselves)?
a) Drug Enforcement Administration
b) European Medicines Agency
c) Pharmaceutical Research and Manufacturers of America (PhRMA)
d) the FDA?
Answer: C) PhRMA.
,◉ Growing demand in the medical community for more complex
data about pharmaceuticals has simplified the pharmaceutical R&D
process?
Answer: False
◉ The landmark FDA Modernization Act of 1997 was a major step
forward in enabling safe and effective new drugs and biologics to be
made available sooner to patients.
Answer: True
◉ Which type system is the best way to deliver healthcare?
Answer: A market-based system.
◉ How would increased pharmaceutical price controls affect the U.S.
healthcare system?
Answer: Increased price controls would stifle innovation.
◉ Which invests a greater percentage of sales in research than the
biotech sector
a) aerospace
b) communications
c) electronics
d) none of these
, Answer: d) none of these
◉ What was the intent of the Bayh-Dole Act and the Stevenson-
Wydler Technology Innovation Act?
Answer: To hasten the commercialization of technologies that
otherwise might not be used.
◉ What did the G10 Medicines Group recently report about the
pharmaceutical industry in the European Union (EU)?
Answer: There is poor collaboration between publicly- and
privately-funded research centers.
◉ The aim of preclinical pharmacological studies is to obtain data on
the safety and effectiveness of the lead compound.
Answer: True
◉ Toxicity information in preclinical studies helps provide
confidence about a drug's safety.
Answer: True
◉ Pharmacological studies using animals are regulated under Good
Laboratory Practice.
Answer: True
◉ What should you do if you receive a shipment from your employer
and you notice that there are twice as many samples as what is
posted on the packing slip?
Answer: Call your Sales Manager and inform him/her of the mistake,
and ask for instructions on proper procedure.
◉ Which area of drug R&D has seen the largest cost increases?
Answer: Clinical trials.
◉ On average, how long does it take for a new drug to be developed
(i.e. from the discovery of the initial compound to FDA approval)?
Answer: 10-15 years
◉ Which of the following agencies is industry-based (i.e. run mainly
by the companies themselves)?
a) Drug Enforcement Administration
b) European Medicines Agency
c) Pharmaceutical Research and Manufacturers of America (PhRMA)
d) the FDA?
Answer: C) PhRMA.
,◉ Growing demand in the medical community for more complex
data about pharmaceuticals has simplified the pharmaceutical R&D
process?
Answer: False
◉ The landmark FDA Modernization Act of 1997 was a major step
forward in enabling safe and effective new drugs and biologics to be
made available sooner to patients.
Answer: True
◉ Which type system is the best way to deliver healthcare?
Answer: A market-based system.
◉ How would increased pharmaceutical price controls affect the U.S.
healthcare system?
Answer: Increased price controls would stifle innovation.
◉ Which invests a greater percentage of sales in research than the
biotech sector
a) aerospace
b) communications
c) electronics
d) none of these
, Answer: d) none of these
◉ What was the intent of the Bayh-Dole Act and the Stevenson-
Wydler Technology Innovation Act?
Answer: To hasten the commercialization of technologies that
otherwise might not be used.
◉ What did the G10 Medicines Group recently report about the
pharmaceutical industry in the European Union (EU)?
Answer: There is poor collaboration between publicly- and
privately-funded research centers.
◉ The aim of preclinical pharmacological studies is to obtain data on
the safety and effectiveness of the lead compound.
Answer: True
◉ Toxicity information in preclinical studies helps provide
confidence about a drug's safety.
Answer: True
◉ Pharmacological studies using animals are regulated under Good
Laboratory Practice.
Answer: True
